Abstract
Recommendations for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal ulceration and cardiovascular (CV) complications were recently made available through an initiative designed in collaboration with leading specialists in South Africa. The prevention of CV complications and NSAID-related ulceration are discussed in two articles for the purposes of this publication. The first article in this two-part series presented an update on NSAID-related CV risk. This is the second article, and provides an update on NSAIDs and gastrointestinal risk.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
